Purchase Order 75N98026P00177
- Not listed
- The National Cancer Institute awarded a firm fixed-price purchase order to Sony Biotechnology Inc. for maintenance services on two government-owned Sony MA900 cell sorters supporting the NCI's Center for Cancer Research Vaccine Branch and Pediatric Oncology Branch. This contract covers option periods 2 and 3, with a combined ceiling value of $335,016 and an ultimate completion date of February 29, 2028. The work will be performed in Potomac, Maryland, and no small business set-aside was utilized...
- The Department of Health and Human Services, National Institutes of Health, National Cancer Institute (NCI) awarded a $388,749.60 firm fixed-price purchase order to Sony Biotechnology Inc. for a Sony MA900 cell sorter. The cell sorter is critical to support the NCI's research mission, particularly for the Laboratory of Tumor Immunology and Biology's efforts to develop novel immunotherapies for cancer treatment. The contract includes preventive maintenance, emergency repair services, software...
- This firm-fixed-price purchase order contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services, to Sony Biotechnology Inc. The $192,019.16 contract is for maintenance services on a Sony multi-function cell sorter utilized by the NCI's Center for Cancer Research, Oncology Surgery Branch. The contract has a base period ending on July 18, 2026 and does not have a set-aside...
- The National Cancer Institute (NCI) awarded a $40.8K firm fixed-price purchase order to Sony Biotechnology Inc. for maintenance services on the Sony ID7000 Spectral Flow Cytometer. The contract, which carries no set-aside designation, is scheduled for completion by March 1, 2027, and will be performed at the NCI facility in Bethesda, Maryland. Sony Biotechnology Inc., based in San Jose, California, is a specialized manufacturer of advanced flow cytometry and imaging instrumentation that has...
- This is a $141,780.00 firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Sony Biotechnology Inc. for a one-year system maintenance service agreement on a Sony MA900 multi-application cell sorter. The contract has four one-year option periods, for a total potential period of performance through September 10, 2025. The contract was awarded on a sole-source basis, as Sony is the only provider capable of...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $19,035 purchase order to Sony Biotechnology Inc.'s San Jose, California division for maintenance services. The prime contractor, Sony Biotechnology Inc., will provide maintenance support under a firm fixed price contract running from September 21, 2023 through September 20, 2024. The award was made using the National Institutes of Health's internal funding to support the National...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $24,750 purchase order to Sony Biotechnology Inc. for a service agreement for Sony MA900 cell sorters. The place of performance will be in Rockville, Maryland. The period of performance is one year, from July 1, 2023 through June 30, 2024. The contract pricing is firm fixed price. No additional details were provided regarding subcontractors or the National Cancer Institute's programs....
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH), National Cancer Institute (NCI), to Sony Biotechnology Inc. for preventative and emergency maintenance services on one government-owned Sony Biotechnology, Inc. SH800S cell sorter. The equipment is critical to ongoing cancer research at the NCI's Center for Cancer Research (CCR) Surgery Branch. The $155,978.10 contract does not utilize a set-aside, and provides...
- Sony Biotechnology Inc. was awarded a $23,895 purchase order by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services. The firm fixed price contract is for equipment maintenance services to be performed over a one year period from January 2024 through January 2025. The place of performance will be Sony Biotechnology's facility located in San Jose, California. No additional details were provided regarding the specific...
- This firm-fixed-price purchase order contract was awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Sony Biotechnology Inc. for preventive maintenance services on one (1) Sony LE-SA800 cell sorter. The contract has a ceiling value of $119,475.00 and a completion date of April 12, 2028. Sony Biotechnology Inc. is a specialized manufacturer and provider of flow cytometry and imaging instrumentation, reagents, and services to...
The National Cancer Institute (NCI), a division of the National Institutes of Health (NIH), awarded a firm fixed-price purchase order contract to Sony Biotechnology Inc. on July 1, 2026, for system maintenance services on the MA900 cell sorter equipment. The contract was conducted as a sole-source procurement based on Sony's exclusive status as the manufacturer and authorized provider of specialized maintenance, repairs, software upgrades, and parts replacement for this proprietary instrument. The contract is not associated with a set-aside designation. The base performance period runs from July 1, 2026 through June 30, 2027, with four one-year option periods extending through June 30, 2031, establishing a potential five-year commitment. The ceiling value for this contract is $135,360.00. Sony Biotechnology Inc., headquartered in San Jose, California, specializes in manufacturing advanced flow cytometry and cell sorting instrumentation for biomedical research applications. As a prime contractor with no identified subcontractors, Sony will provide factory-trained Field Service Engineers to deliver the preventative maintenance services critical to sustaining the NCI's laboratory capabilities in cancer research and related biomedical studies. The work will be performed at the NCI facility in Bethesda, Maryland. This contract reflects the NCI's broader procurement strategy of maintaining cutting-edge scientific equipment necessary to support its research mission in oncology and translational science.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Notice of Intent to Sole Source for Ongoing Preventative Maintenance Service | PCA-NCI-00670 | Department of Health and Human Services National Institutes of Health Office of Logisitics and Acquisition Operations | Pre-Solicitation 1/1 | 3/16/26, 1:35 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.1k | 3/24/26 |